
Tonix Pharmaceuticals Holding Corporation (TNXP)
NASDAQ
Year End December 30 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -77.853 | -110.621 | -152.125 | -92.556 | -54.433 | -50.098 | -61.375 | -81.952 |
Return on Equity (%) | -84.531 | -121.603 | -187.975 | -107.503 | -60.246 | -54.885 | -74.612 | -106.116 |
Return on Invested Capital (%) | -85.521 | -109.493 | -175.347 | -104.448 | -60.362 | -52.717 | -74.21 | -60.786 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | -1501.777 | -1288.25 |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | -1501.777 | -1288.25 |
Book Value Per Share | 3.128 | 7.218 | 1.09 | 0.425 | 0.441 | 2.142 | 3.531 | 0.734 |
Earnings Per Share | -2.698 | -8.999 | -3.644 | -0.253 | -0.186 | -1.208 | -4.345 | -0.685 |
Cash Per Share | 3.256 | 7.674 | 1.318 | 0.374 | 0.36 | 1.243 | 0.929 | 0.52 |
Working Capital Per Share | 3.106 | 7.174 | 1.033 | 0.379 | 0.337 | 1.164 | 1.076 | 0.53 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | 0.273 | 0.03 |
EBIT Per Share | -2.698 | -7.998 | -3.354 | -0.245 | -0.186 | -1.139 | -4.345 | -0.685 |
EBITDA Per Share | -2.698 | -7.998 | -3.354 | -0.245 | -0.186 | -1.139 | -4.345 | -0.685 |
Free Cash Flow Per Share | -2.706 | -9.014 | -3.645 | -0.212 | -0.115 | -0.723 | -4.211 | -0.702 |
Year End December 30 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 7.83M | 3.25M | 8.53M | 206.01M | 496.25M | 93.74M | N/A | N/A |
Year End December 30 2024 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Shares Outstanding | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | -601.894 | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | -601.894 | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 207.51M |
Price to Earnings Ratio | -1.6 |
Price to Sales Ratio | 20.56 |
Price to Cash Ratio | 2.1 |
Price to Book Ratio | 1.49 |
Dividend Yield | - |
Shares Outstanding | 7.32M |
Average Volume (1 week) | 1.81M |
Average Volume (1 Month) | 873.76k |
52 Week Change | -95.28% |
52 Week High | 624.00 |
52 Week Low | 6.76 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.